AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35912711 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 804
Study 35912711 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 804
Study 35912711 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 804
Study 35912711 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak C-reactive protein (CRP)
Number of subjects: 804
Study 35912711 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadir platelet count
Number of subjects: 804
Study 33984691 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a partner
Number of subjects: 0
Study 33984691 — intervention group
Group type: COMPARATOR
Intervention: Non-partnered persons
Number of subjects: 0
Study 35850030 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger exercise
Number of subjects: 232
Study 35850030 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 232
Study 34186135 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual prostate-specific antigen (PSA) tests for 6 years and digital rectal exams (DRE) for 4 years
Number of subjects: 2855
Study 34186135 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 2855
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: CombinADO intervention
Number of subjects: 0
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: Media campaign
Number of subjects: 0
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: Toolkit for providers
Number of subjects: 0
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-support groups
Number of subjects: 0
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: Support groups for parents/caregivers
Number of subjects: 0
Study 35487546 — intervention group
Group type: EXPERIMENTAL
Intervention: Discreet pill containers
Number of subjects: 0
Study 32330670 — intervention group
Group type: EXPERIMENTAL
Intervention: TACTICS implementation (context-tailored implementation approach) after provider training in prolonged exposure therapy (PE) for PTSD.
Number of subjects: 0
Study 32330670 — intervention group
Group type: COMPARATOR
Intervention: Provider training in prolonged exposure therapy (PE) alone.
Number of subjects: 0
Study 36159368 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepectoral implant placement
Number of subjects: 0
Study 36159368 — intervention group
Group type: COMPARATOR
Intervention: Subpectoral implant placement
Number of subjects: 0
Study 32902856 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking Relapse Prevention (SRP) intervention including a targeted educational DVD and a validated self-help intervention
Number of subjects: 412
Study 32902856 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 412
Study 32902856 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking Relapse Prevention (SRP) intervention
Number of subjects: 412
Study 36260465 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior modification using a self-designed dental storybook
Number of subjects: 380
Study 36260465 — intervention group
Group type: COMPARATOR
Intervention: Behavior modification without storybook
Number of subjects: 380
Study 34162912 — intervention group
Group type: EXPERIMENTAL
Intervention: Apology (yes)
Number of subjects: 0
Study 34162912 — intervention group
Group type: COMPARATOR
Intervention: Apology (no)
Number of subjects: 0
Study 34162912 — intervention group
Group type: EXPERIMENTAL
Intervention: High relationship value
Number of subjects: 0
Study 34162912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low relationship value
Number of subjects: 0
Study 33002131 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 126
Study 33002131 — intervention group
Group type: COMPARATOR
Intervention: Standard anticoagulants
Number of subjects: 126
Study 36263035 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-paced breathing (4sec inhalation, 6sec exhalation for 20 minutes 3x daily)
Number of subjects: 46
Study 36263035 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 46
Study 36263035 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-paced breathing (dose-response relationship)
Number of subjects: 46
Study 36263035 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-paced breathing
Number of subjects: 46
Study 32316765 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA)
Number of subjects: 66
Study 32316765 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 66
Study 32316765 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control (WL)
Number of subjects: 66
Study 32131866 — intervention group
Group type: EXPERIMENTAL
Intervention: IC43 100 μg
Number of subjects: 800
Study 32131866 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 800
Study 34232458 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous electroencephalography (cEEG) monitoring initiated on admission to intensive care, with a focus on the burden of ictal‐interictal continuum (IIC) patterns, including seizures.
Number of subjects: 142
Study 34232458 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe ictal‐interictal continuum (IIC) patterns identified through cEEG monitoring.
Number of subjects: 142
Study 33168128 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T3) supplementation
Number of subjects: 208
Study 33168128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 34896412 — intervention group
Group type: EXPERIMENTAL
Intervention: Vancomycin-soaked sponges
Number of subjects: 1037
Study 34896412 — intervention group
Group type: COMPARATOR
Intervention: Saline-soaked sponges (Control)
Number of subjects: 1037
Study 33839603 — intervention group
Group type: EXPERIMENTAL
Intervention: pembrolizumab + chemotherapy
Number of subjects: 59
Study 32826103 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated individually randomized RCTs
Number of subjects: 0
Study 32826103 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled human challenge trials (CHI)
Number of subjects: 0
Study 32826103 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide distribution through emergency use authorization
Number of subjects: 0
Study 35855386 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil (5 drops, twice a day for one month)
Number of subjects: 68
Study 35855386 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day for one month)
Number of subjects: 68
Study 33954198 — intervention group
Group type: EXPERIMENTAL
Intervention: PECS II (0.5% ropivacaine 25 ml)
Number of subjects: 40
Study 33954198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 40
Study 36209104 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care intervention (add-on intervention)
Number of subjects: 197
Study 36209104 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 197
Study 36209104 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 197
Study 33939376 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful yoga intervention (9 weeks)
Number of subjects: 11
Study 32971764 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing exerciser (CE) in addition to conventional physiotherapy (PT)
Number of subjects: 22
Study 32971764 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (PT)
Number of subjects: 22
Study 32971764 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing exerciser (CE)
Number of subjects: 22
Study 35616436 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone and acamprosate (alone and in combination)
Number of subjects: 1168
Study 33132018 — intervention group
Group type: EXPERIMENTAL
Intervention: FFC‐AL‐EIT intervention
Number of subjects: 794
Study 33127637 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone-based peer support
Number of subjects: 501
Study 35614292 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 125
Study 35614292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 34898563 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 2745
Study 34898563 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 2745
Study 616636432 — intervention group
Group type: EXPERIMENTAL
Intervention: Science to Service Laboratory (SSL)
Number of subjects: 60
Study 616636432 — intervention group
Group type: COMPARATOR
Intervention: Training as Usual (TAU)
Number of subjects: 60
Study 32785710 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 0.5 mg/kg intravenously twice daily for 5 days
Number of subjects: 393
Study 32785710 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 393
Study 32785710 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 393
Study 35303894 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity strategies
Number of subjects: 0
Study 35303894 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity strategies
Number of subjects: 0
Study 32188386 — intervention group
Group type: EXPERIMENTAL
Intervention: Established markers of inflammation (e.g., C-reactive protein)
Number of subjects: 0
Study 32188386 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer inflammatory markers (e.g., lipoprotein-associated phospholipase A2, cytokines, myeloperoxidase)
Number of subjects: 0
Study 32188386 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory and pleiotropic drugs
Number of subjects: 0
Study 32438719 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of grapefruit, bitter orange, and olive extracts for eight weeks
Number of subjects: 51
Study 32438719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 32684076 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-guided exercise intervention
Number of subjects: 14
Study 32684076 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual control group
Number of subjects: 14
Study 32846424 — intervention group
Group type: COMPARATOR
Intervention: Peptide phage display approach using serum samples from patients
Number of subjects: 4
Study 32846424 — intervention group
Group type: COMPARATOR
Intervention: Peptide phage display approach
Number of subjects: 4
Study 33238154 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg)
Number of subjects: 25
Study 33238154 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 32444161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone app
Number of subjects: 128
Study 32444161 — intervention group
Group type: COMPARATOR
Intervention: Telephone assistance
Number of subjects: 128
Study 35130492 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient palliative care intervention (n=61)
Number of subjects: 120
Study 35130492 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=59)
Number of subjects: 120
Study 32398848 — intervention group
Group type: EXPERIMENTAL
Intervention: Localized intraoperative laser retinopexy
Number of subjects: 93
Study 32398848 — intervention group
Group type: COMPARATOR
Intervention: 360° intraoperative laser retinopexy
Number of subjects: 93
Study 35894768 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine hypoglycemic drugs + resistance training (AE + RT)
Number of subjects: 30
Study 35894768 — intervention group
Group type: COMPARATOR
Intervention: Routine hypoglycemic drugs
Number of subjects: 30
Study 33771645 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile management (MM)
Number of subjects: 309
Study 33771645 — intervention group
Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 309
Study 35894993 — intervention group
Group type: EXPERIMENTAL
Intervention: Midfoot joint mobilization
Number of subjects: 20
Study 35894993 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 20
Study 34128724 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning (DL) reconstruction of accelerated bSSFP cardiac MRI
Number of subjects: 50
Study 34128724 — intervention group
Group type: COMPARATOR
Intervention: Balanced steady-state free precession (bSSFP) MRI
Number of subjects: 50
Study 32087336 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical decision support (CDS) tool provided to primary care clinicians (PCPs) and psychiatrists during patient visits.
Number of subjects: 10347
Study 32087336 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to CDS tool for PCPs and psychiatrists.
Number of subjects: 10347
Study 32087336 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 10347
Study 36287634 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial Scratching (ES)
Number of subjects: 0
Study 36287634 — intervention group
Group type: COMPARATOR
Intervention: Control (no Endometrial Scratching)
Number of subjects: 0
Study 35585475 — intervention group
Group type: EXPERIMENTAL
Intervention: Education + Media + PN
Number of subjects: 428
Study 35585475 — intervention group
Group type: COMPARATOR
Intervention: Education + Media
Number of subjects: 428
Study 33499570 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment every 1 week
Number of subjects: 20
Study 33499570 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment every 2 weeks
Number of subjects: 20
Study 33499570 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment every 3 weeks
Number of subjects: 20
Study 33499570 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment every 4 weeks
Number of subjects: 20
Study 36385466 — intervention group
Group type: EXPERIMENTAL
Intervention: OT-guided cognitive intervention protocol
Number of subjects: 70
Study 36385466 — intervention group
Group type: COMPARATOR
Intervention: Standard delirium prevention protocol
Number of subjects: 70
Study 34284099 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment in poor CYP2D6 metabolizers
Number of subjects: 1440
Study 34284099 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment in intermediate CYP2D6 metabolizers
Number of subjects: 1440
Study 34284099 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment in normal CYP2D6 metabolizers
Number of subjects: 1440
Study 34284099 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen treatment in ultrarapid CYP2D6 metabolizers
Number of subjects: 1440
Study 35162842 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal intralesional injections of dexamethasone (2 mL; 4 gm/mL)
Number of subjects: 130
Study 35162842 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronidase (1500 IU)
Number of subjects: 130
Study 34541864 — intervention group
Group type: EXPERIMENTAL
Intervention: TARE plus chemotherapy
Number of subjects: 428
Study 34541864 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 428
Study 34924512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral-Based Physical Therapy (CBPT-Trauma)
Number of subjects: 325
Study 34924512 — intervention group
Group type: COMPARATOR
Intervention: Education program
Number of subjects: 325
Study 32631130 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile interventionist approach as an add-on to assertive community treatment (ACT)
Number of subjects: 49
Study 32631130 — intervention group
Group type: COMPARATOR
Intervention: Assertive community treatment (ACT) alone
Number of subjects: 49
Study 35552458 — intervention group
Group type: EXPERIMENTAL
Intervention: Precision prevention materials incorporating MC1R genetic risk (higher/average)
Number of subjects: 1134
Study 35552458 — intervention group
Group type: COMPARATOR
Intervention: Generic prevention (standard) materials
Number of subjects: 1134
Study 33965364 — intervention group
Group type: EXPERIMENTAL
Intervention: Online weight management platform with weekly coaching calls (weeks 1–12) tapered to bi-weekly calls (weeks 12–24)
Number of subjects: 35
Study 33965364 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no access to online platform or coaching calls)
Number of subjects: 35
Study 32907547 — intervention group
Group type: EXPERIMENTAL
Intervention: BELIEF protocol (two face-to-face counseling sessions at 24 and 34 weeks of pregnancy, plus eight weekly telephone counseling sessions)
Number of subjects: 80
Study 32907547 — intervention group
Group type: EXPERIMENTAL
Intervention: BELIEF protocol
Number of subjects: 80
Study 32907547 — intervention group
Group type: COMPARATOR
Intervention: Control group (received only prenatal routine care)
Number of subjects: 80
Study 35641889 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-delivered Intensive Sleep Retraining (ISR)
Number of subjects: 12
Study 33991186 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 877
Study 33991186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 877
Study 32290815 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT-ILE (50 hours over two weeks)
Number of subjects: 50
Study 32290815 — intervention group
Group type: COMPARATOR
Intervention: Usual motor activity (including regular rehabilitation)
Number of subjects: 50
Study 35158444 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest
Number of subjects: 0
Study 35158444 — intervention group
Group type: COMPARATOR
Intervention: Logistic Regression
Number of subjects: 0
Study 35158444 — intervention group
Group type: EXPERIMENTAL
Intervention: Ridge
Number of subjects: 0
Study 35158444 — intervention group
Group type: EXPERIMENTAL
Intervention: LASSO
Number of subjects: 0
Study 33981369 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplement preparation (PSP)
Number of subjects: 120
Study 32090630 — intervention group
Group type: EXPERIMENTAL
Intervention: RT‐HIIT
Number of subjects: 240
Study 32090630 — intervention group
Group type: EXPERIMENTAL
Intervention: AT‐HIIT
Number of subjects: 240
Study 32090630 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 240
Study 36152764 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% IV albumin 1.5 g/kg weekly infusions
Number of subjects: 48
Study 36152764 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 48
Study 34484562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin-rich mulberry milk (2 servings daily)
Number of subjects: 0
Study 34484562 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin-rich mulberry milk (1 serving daily)
Number of subjects: 0
Study 32478917 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term abdominal drain
Number of subjects: 36
Study 32478917 — intervention group
Group type: COMPARATOR
Intervention: Large-volume paracentesis
Number of subjects: 36
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Supper
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon snack
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning snack
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch fat intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Supper fat intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch protein intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Supper protein intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast carbohydrate intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Snacks carbohydrate intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Variation in morning snack intake
Number of subjects: 740
Study 35930067 — intervention group
Group type: EXPERIMENTAL
Intervention: Snack intakes with age
Number of subjects: 740
Study 35680433 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning neural network for automated segmentation of L3 CT slices
Number of subjects: 536
Study 34052593 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB)
Number of subjects: 80
Study 34052593 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB)
Number of subjects: 80
Study 32673160 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training at 65-85% V̇o2peak for 24 weeks, prescribed dose of 8 kcal·kg body wt‐1·wk‐1 (8 KKW) or 20 KKW
Number of subjects: 110
Study 32673160 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training at 65-85% V̇o2peak for 24 weeks
Number of subjects: 110
Study 32673160 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher relative perceived exertion
Number of subjects: 110
Study 35674571 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations (MOPs)
Number of subjects: 30
Study 35674571 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 34020012 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% VO2max exercise
Number of subjects: 210
Study 34020012 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% VO2max exercise
Number of subjects: 210
Study 34020012 — intervention group
Group type: COMPARATOR
Intervention: Seated rest
Number of subjects: 210
Study 35244702 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate APOL1 genetic testing results
Number of subjects: 2050
Study 35244702 — intervention group
Group type: COMPARATOR
Intervention: Delayed APOL1 genetic testing results (control)
Number of subjects: 2050
Study 34074289 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 1.6 × 10^9 CFU for 12 weeks
Number of subjects: 44
Study 34074289 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules for 12 weeks
Number of subjects: 44
Study 34074289 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted diet
Number of subjects: 44